Medications for Breast Neoplasms

151 results
Abraxis BioScience, LLC
Usage: ABRAXANE is indicated for treating metastatic breast cancer after previous chemotherapy failure, first-line therapy for non-small cell lung cancer with carboplatin in inoperable cases, and first-line treatment for metastatic adenocarcinoma of the pancreas in combination with gemcitabine.
Upsher-Smith Laboratories, LLC
Usage: Anastrozole is indicated for the adjuvant treatment of hormone receptor-positive early breast cancer in postmenopausal women, as well as for first-line and second-line treatments of locally advanced or metastatic breast cancer. It is effective following disease progression after tamoxifen therapy.
AiPing Pharmaceutical Inc
Usage: Anastrozole is indicated for the adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer, as well as for first-line and second-line treatment of locally advanced or metastatic breast cancer, particularly following disease progression after tamoxifen therapy.
American Health Packaging
Usage: Anastrozole tablets are indicated for adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer, first-line treatment of hormone receptor-positive or unknown locally advanced or metastatic breast cancer, and second-line treatment of advanced breast cancer following disease progression on tamoxifen therapy.
Natco Pharma Limited
Usage: Anastrozole tablets are indicated for adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer, as well as for first-line treatment of hormone receptor-positive or unknown locally advanced or metastatic breast cancer. It is also used as a second-line treatment for advanced breast cancer after tamoxifen therapy.
Ascend Laboratories, LLC
Usage: Anastrozole tablets are indicated for treating advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy. Responders to previous tamoxifen treatment are essential, as those with ER-negative disease or prior lack of response rarely benefit from anastrozole.
Synthon Pharmaceuticals Inc
Usage: Anastrozole Tablets are indicated for the adjuvant treatment of hormone receptor-positive early breast cancer in postmenopausal women, as well as for first-line treatment of locally advanced or metastatic breast cancer (hormone receptor-positive or unknown) and second-line treatment after tamoxifen therapy.
NuCare Pharmaceuticals,Inc.
Usage: Anastrozole tablets are indicated for adjuvant treatment of hormone receptor-positive early breast cancer in postmenopausal women, first-line treatment of locally advanced or metastatic breast cancer (hormone receptor-positive or unknown), and second-line treatment for advanced breast cancer after disease progression on tamoxifen.
Ascend Laboratories, LLC
Usage: Anastrozole tablets are indicated for advanced breast cancer treatment in postmenopausal women whose disease progressed after tamoxifen therapy. It is less effective in patients with ER-negative disease or those who did not respond to prior tamoxifen treatment.
Boscogen, Inc.
Usage: Anastrozole is indicated for treating advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy. It is less effective in patients with ER-negative disease or those who did not respond to earlier tamoxifen treatment.
  • ...